CClinicalTrials.gg
RecruitingNCT07603648Multi-site APUpdated May 22, 2026

Immediate Electrophysiological Effects of Different Atrial Pacing Sites on P-Wave Characteristics

An interventional study of Multi-site short-time pacing in Pacing Therapy and Cardiac Pacing, sponsored by Shanghai Tong Ren Hospital. Recruiting at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Shanghai Tong Ren Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective, single-center, non-randomized, within-subject interventional study. The purpose is to compare the immediate effects of different atrial pacing sites on atrial electrical activation, as reflected by P-wave characteristics on surface electrocardiography (ECG).

During pacemaker implantation, short-term pacing will be performed sequentially at multiple predefined atrial sites, including the right atrial appendage (RAA), atrial septum, Bachmann's bundle (BB) area, and posterosuperior bundle (PSB) regions. ECG parameters will be recorded at each site to evaluate differences in P-wave duration and morphology.

Read the detailed description

Atrial pacing site plays a key role in determining atrial activation sequence and interatrial synchrony. Conventional right atrial appendage (RAA) pacing has been associated with delayed and non-physiological atrial activation, whereas alternative sites such as the atrial septum and Bachmann's bundle (BB) may better preserve physiological conduction.Posterosuperior bundle (PSB) pacing has recently been proposed as a novel physiological atrial pacing strategy.

This study is designed to evaluate the acute electrophysiological effects of different atrial pacing sites within the same individual. During routine pacemaker implantation, sequential short-term pacing will be performed at predefined atrial sites (RAA, atrial septum, BB area, high PSB, and low PSB), with simultaneous 12-lead ECG recording.

The primary objective is to compare P-wave duration across pacing sites. Secondary analyses include P-wave morphology and polarity. The study aims to identify the atrial pacing site that most closely approximates physiological atrial activation and to provide mechanistic insights to guide optimal site selection.

02

Conditions studied

  • Pacing Therapy
  • Cardiac Pacing

Keywords

  • atrial pacing
  • physiological pacing
  • Bachmann's bundle pacing
  • Posterosuperior bundle pacing
03

In context

Lead sponsor

Shanghai Tong Ren Hospital is the lead sponsor of 16 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ≥18 years
  • Sinus rhythm at baseline
  • Indication for permanent pacemaker implantation with planned atrial lead placement
  • Willing and able to provide written informed consent

Exclusion criteria

Exclusion Criteria:

  • Long-standing persistent or permanent atrial fibrillation, or prior atrioventricular node ablation
  • Prior cardiac implantable electronic device (CIED) requiring revision, replacement, or upgrade
  • Indication for implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D)
  • Significant valvular heart disease, cardiomyopathy, or prior cardiac surgery
  • Angina or acute myocardial infarction within 3 months before enrollment
  • Chronic use of antiarrhythmic drugs
  • Severe hepatic or renal dysfunction, or other serious systemic diseases
  • Participation in another clinical study that may interfere with the objectives of this study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (estimated)

Study arms

  • Experimental
    single arm-sequential multi-site atrial pacing

    Participants will undergo sequential short-term atrial pacing at multiple predefined anatomical sites during standard pacemaker implantation, including the right atrial appendage (RAA), atrial septum, Bachmann's bundle (BB) area, and posterosuperior bundle (PSB) regions (high and low levels). PSB pacing will be kept with the remaining implantation procedure.

    Procedure: Multi-site short-time pacing

Interventions

  • ProcedureMulti-site short-time pacing

    Short-time atrial pacing at right atrial appendage (RAA), atrial septum, Bachmann's bundle (BB) area, and posterosuperior bundle (PSB) regions (high and low levels) during regular pacemaker implantation procedures are applied for acute electrocardiogram and echocardiogram testings.

06

What researchers measure

Primary outcomes

  1. Atrial-paced ECG P-wave duration

    Time frame: During implantation

Secondary outcomes

  1. Atrial-paced ECG P-wave morphology

    Time frame: During implantation

  2. Atrial-paced ECG P-wave polarity in inferior leads (II, III, aVF)

    Time frame: During implantation

07

Study locations

1 of 2 sites recruiting
  • Affiliated Hospital of Zunyi Medical College
    Zunyi, Guizhou, China
    Not yet recruiting
  • Tong Ren Hospital, Shanghai Jiaotong University School of Medicine
    Shanghai, Shanghai Municipality 200336, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07603648
Lead sponsor
Shanghai Tong Ren Hospital
Responsible party
Sponsor
First posted
May 22, 2026
Start date
Mar 31, 2026
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
May 22, 2026

Study contacts

Zhaohui Qiu
Contact
qzh3503@shtrhospital.com
+862152039999

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion